HuGE Literature Finder
Records
1
-
9
| Prognostic Significance of Altered ATRX/DAXX Gene in Pancreatic Neuroendocrine Tumors: A Meta-Analysis. Frontiers in endocrinology 2021 12 691557. Wang Fei, Xu Xiaowu, Ye Zeng, Qin Yi, Yu Xianjun, Ji Shunro |
| ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors. Human pathology 2018 Aug . Chou Angela, Itchins Malinda, de Reuver Philip R, BSc Jennifer Arena, BSc Adele Clarkson, BSc Amy Sheen, BSc Loretta Sioson, MChD Veronica Cheung, Perren Aurel, Nahm Christopher, Mittal Anubhav, Samra Jaswinder S, Pajic Marina, Gill Anthony |
| DAXX Mutation Status of Embolization-Treated Neuroendocrine Tumors Predicts Shorter Time to Hepatic Progression. Journal of vascular and interventional radiology : JVIR 2018 11 29 (11): 1519-1526. Ziv Etay, Rice Samuel L, Filtes John, Yarmohammadi Hooman, Boas F Edward, Erinjeri Joseph P, Petre Elena Nadia, Brody Lynn A, Brown Karen T, Covey Anne M, Getrajdman George I, Maybody Majid, Raj Nitya, Sofocleous Constantinos T, Solomon Stephen B, Reidy-Lagunes Dia |
| Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel. Oncotarget 2017 Nov 8 (55): 93464-93475. Gleeson Ferga C, Voss Jesse S, Kipp Benjamin R, Kerr Sarah E, Van Arnam John S, Mills John R, Marcou Cherisse A, Schneider Amber R, Tu Zheng Jin, Henry Michael R, Levy Michael |
| Serotonin, ATRX, and DAXX Expression in Pituitary Adenomas: Markers in the Differential Diagnosis of Neuroendocrine Tumors of the Sellar Region. The American journal of surgical pathology 2017 Jul . Casar-Borota Olivera, Botling Johan, Granberg Dan, Stigare Jerker, Wikström Johan, Boldt Henning Bünsow, Kristensen Bjarne Winther, Pontén Fredrik, Trouillas Jacqueli |
| Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Jul . Singhi Aatur D, Liu Ta-Chiang, Roncaioli Justin L, Cao Dengfeng, Zeh Herbert J, Zureikat Amer H, Tsung Allan, Marsh J Wallis, Lee Kenneth K, Hogg Melissa E, Bahary Nathan, Brand Randall, McGrath Kevin M, Slivka Adam, Cressman Kristi L, Fuhrer Kimberly, O'Sullivan Roderick |
| Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors. International journal of biological sciences 2016 12 (12): 1523-1532. Chou Wen-Chi, Lin Po-Han, Yeh Yi-Chen, Shyr Yi-Ming, Fang Wen-Liang, Wang Shin-E, Liu Chun-Yu, Chang Peter Mu-Hsin, Chen Ming-Han, Hung Yi-Ping, Li Chung-Pin, Chao Yee, Chen Ming-Hua |
| KRAS and DAXX/ATRX gene mutations are correlated with the clinicopathological features, advanced diseases, and poor prognosis in Chinese patients with pancreatic neuroendocrine tumors. International journal of biological sciences 2014 10 (9): 957-65. Yuan Fei, Shi Min, Ji Jun, Shi Hailong, Zhou Chenfei, Yu Yingyan, Liu Bingya, Zhu Zhenggang, Zhang J |
| DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science (New York, N.Y.) 2011 1 331 (6021): 1199-203. Jiao Yuchen, Shi Chanjuan, Edil Barish H, de Wilde Roeland F, Klimstra David S, Maitra Anirban, Schulick Richard D, Tang Laura H, Wolfgang Christopher L, Choti Michael A, Velculescu Victor E, Diaz Luis A, Vogelstein Bert, Kinzler Kenneth W, Hruban Ralph H, Papadopoulos Nickol |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 07, 2023
- Content source: